Valtruis

Valtruis is a private equity firm dedicated to investing in and partnering with healthcare companies aiming to realign and transform the U.S. healthcare system through value-based care models. Backed by Welsh, Carson, Anderson & Stowe (WCAS), Valtruis leverages over 40 years of experience in the healthcare sector to support innovative companies in their growth and development. The firm focuses on reducing costs, expanding access, increasing quality, and improving patient experiences by addressing systemic barriers in the healthcare industry.

The firm's investment strategy encompasses a range of stages, including early-stage development, growth, late-stage, pre-IPO, and buyouts. Valtruis primarily concentrates on the healthcare and technology sectors within the United States. Its portfolio includes companies such as Wellvana Health, which raised $84 million in a capital raise co-led by Valtruis to drive innovation in value-based care enablement. Additionally, Valtruis has invested in Wayspring, a value-based care entity focused on substance use disorder, which secured a $75 million investment from Valtruis and other leading healthcare investors.

Valtruis is headquartered in Chicago, Illinois, and operates under the leadership of Managing Partners Anna Haghgooie, Tracy Bahl, and Karey Witty. The firm is committed to accelerating meaningful change in healthcare by providing functional expertise, access to capital, and an expansive network to its partner companies. Through these efforts, Valtruis aims to break through systemic barriers in the healthcare sector to reduce costs, expand access, increase quality, and radically improve the patient experience.